← Back
$CRSP All transactions

CRISPR Therapeutics AG

A

$ Value

$0

Shares

13,000

Price

$0

Filed

Jun 6

Insider

Name

Mahatme Sandesh

Title

CIK

0001511034

Roles

Director

Transaction Details

Transaction Date

2025-06-05

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

13,000

Footnotes

This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders.

Filing Info

Accession No.

0000950170-25-083269

Form Type

4

Issuer CIK

0001674416

Mahatme Sandesh's History

Date Ticker Type Value
2025-07-09 VOR A $0
2025-06-05 CRSP A $0

Other Insiders at CRSP (90d)

Insider Bought Sold Last
Kulkarni Samarth
Chief Executive Officer
$469K 2026-03-23
KASINGER JAMES R.
General Counsel and Secretary
$149K 2026-03-23
Prasad Raju
Chief Financial Officer
$173K 2026-03-23
Patel Naimish
Chief Medical Officer
2026-03-20